Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.

Suppr

超能文献

出版信息

Transplant Proc. 1997 Feb-Mar;29(1-2):348-9. doi: 10.1016/s0041-1345(96)00302-8.

DOI:10.1016/s0041-1345(96)00302-8

PMID:9123033

Abstract

摘要

相似文献

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):348-9. doi: 10.1016/s0041-1345(96)00302-8.

Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.

Transplant Proc. 1997 Feb-Mar;29(1-2):342-3. doi: 10.1016/s0041-1345(96)00300-4.

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.

Transplantation. 2001 Jul 27;72(2):245-50. doi: 10.1097/00007890-200107270-00014.

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

Transplantation. 1995 Aug 15;60(3):225-32. doi: 10.1097/00007890-199508000-00003.

A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.

Transplant Proc. 1998 Dec;30(8):4098. doi: 10.1016/s0041-1345(98)01356-6.

A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.

Transplantation. 2012 Feb 27;93(4):437-43. doi: 10.1097/TP.0b013e31824215b7.

Triple therapy with mycophenolate mofetil versus azathioprine.

Transplant Proc. 1999 Feb-Mar;31(1-2):1144-6. doi: 10.1016/s0041-1345(98)01939-3.

Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.

Transplant Proc. 1999 Feb-Mar;31(1-2):1131-2. doi: 10.1016/s0041-1345(98)01933-2.

Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.

Transplant Proc. 1998 Jun;30(4):1562-3. doi: 10.1016/s0041-1345(98)00358-3.

The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.

Transplant Proc. 2000 Nov;32(7):2040-2. doi: 10.1016/s0041-1345(00)01549-9.

引用本文的文献

De Novo Carcinoma after Solid Organ Transplantation to Give Insight into Carcinogenesis in General-A Systematic Review and Meta-Analysis.

Cancers (Basel). 2021 Mar 5;13(5):1122. doi: 10.3390/cancers13051122.

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats.

BMC Pharmacol Toxicol. 2018 Jul 4;19(1):39. doi: 10.1186/s40360-018-0234-1.

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.

Cochrane Database Syst Rev. 2015 Dec 3;2015(12):CD007746. doi: 10.1002/14651858.CD007746.pub2.

Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients.

Pediatr Nephrol. 2008 Oct;23(10):1859-65. doi: 10.1007/s00467-008-0877-z. Epub 2008 Jul 2.

Time-dependent clearance of mycophenolic acid in renal transplant recipients.

Br J Clin Pharmacol. 2007 Jun;63(6):741-52. doi: 10.1111/j.1365-2125.2006.02841.x. Epub 2007 Jan 3.

Immunosuppression for long-term maintenance of renal allograft function.

Drugs. 2004;64(12):1325-38. doi: 10.2165/00003495-200464120-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验